PDL Biopharma
PDLI
#8043
Rank
โ‚น25.26 B
Marketcap
โ‚น221.22
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Market capitalization of PDL Biopharma (PDLI)

Last known market cap: โ‚น25.26 Billion

As of December 2025 PDL Biopharma has a market cap of โ‚น25.26 Billion. This makes PDL Biopharma the world's 8043th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of PDL Biopharma from 2001 to 2021

End of year Market Cap

Year Marketcap Change
2021โ‚น21.00 B1.77%
2020โ‚น20.63 B-28.27%
2019โ‚น28.76 B3.91%
2018โ‚น27.68 B2.52%
2017โ‚น27.00 B13.22%
2016โ‚น23.84 B-38.29%
2015โ‚น38.64 B-51.23%
2014โ‚น79.25 B8.61%
2013โ‚น72.96 B35.39%
2012โ‚น53.89 B17.51%
2011โ‚น45.86 B17.65%
2010โ‚น38.98 B2.47%
2009โ‚น38.04 B7.17%
2008โ‚น35.49 B-56.09%
2007โ‚น80.84 B-21.19%
2006โ‚น102.58 B-28.42%
2005โ‚น143.31 B67.1%
2004โ‚น85.76 B12.09%
2003โ‚น76.51 B110.49%
2002โ‚น36.35 B-74.15%
2001โ‚น140.61 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Compugen
CGEN
โ‚น12.89 B-48.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚น15.982 T 63,147.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚น79.21 B 213.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น86.430 T 341,934.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น13.86 B-45.11%๐Ÿ‡บ๐Ÿ‡ธ USA